PROVIDER PROFILE · NPI 1679502785

Alberto Comas EspinalM.D.

PRACTICEWADSWORTH MEDICAL, PCSee all providers at this practice →

General PracticeNew York, NYI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

206

Unique beneficiaries

—

Total services

272

Distinct HCPCS

Medicare payment

$14K

Peer benchmark

Total Medicare services vs. 153 General Practice providers in NY — below median (cohort median 456).

PRESCRIBING · PART D · 2024

Total Rx claims

13,307

Beneficiaries

—

Total drug cost

$1.5M

Distinct drugs

150

Brand share

32.7%

Top prescribed drugs

Atorvastatin Calcium613 claims

Omeprazole600 claims

Albuterol Sulfate392 claims

Ibandronate Sodium392 claims

Metformin Hcl381 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$73

Payment records

By payment type

Food and Beverage$73

REFERRAL NETWORK

Where Alberto Comas Espinal's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 5 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Lenco Diagnostic Laboratories,inc. Clinical Laboratory · Brooklyn, NY	61	170
Claudia Serrano-Gomez Cardiology · New York, NY	15	59
Walter Bottizer Diagnostic Radiology · Rye, NY	15	21
Laboratory Corporation Of America Holdings Clinical Laboratory · Raritan, NJ	12	30
THE NEW YORK AND PRESBYTERIAN HOSPITAL	12	30

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history